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Background: Past research suggests that women, as compared with men, have worse 
survival after an acute myocardial infarction (AMI). However, little is known about whether 
women also have worse health status (symptoms, function, and quality of life [QOL]) after an 
AMI. 
Methods: Across two multi-centered AMI registries (PREMIER and TRIUMPH), we 
examined whether there were sex differences in health status recovery among 4,555 AMI 
patients using the validated disease-specific Seattle Angina Questionnaire (SAQ). We compared 
1-year change in SAQ angina frequency and QOL scores for men and women with hierarchical 
linear regression models that adjusted for demographics, clinical comorbidities, socio-economic 
factors, and medication treatment. To facilitate interpretability, we also compared the presence of 
any angina as a dichotomous variable at 1 year (SAQ angina frequency score <100 vs. 100).  
Results: Of 4,555 AMI patients, 1,481(32.5%) were women. Women were older, more 
frequently of black race and widowed, and were more likely to have economic barriers to care, 
including financial difficulty affording medications and be unemployed. Compared with men, 
women had lower mean baseline (61.3±23.4 vs. 64.9±22.7) and 1-year (80.3±21.5 vs. 84.2±19.0) 
QOL scores, and less model-adjusted improvement in QOL at 1-year (-2.60 SAQ points; 95% 
CI: -1.31, -3.90; P<0.001). Although women and men had similar baseline SAQ angina scores 
(85.0±20.7 vs. 85.8±20.4), women had more frequent angina at 1-year (91.6±17.6 vs. 
94.1±14.9), which resulted in less model-adjusted improvement in angina frequency scores after 
adjustment for all covariates (-2.85 SAQ points; 95% CI: -1.34, -4.36; P<0.001).  This also 




Conclusion: Compared with men, women have worse health status recovery after AMI 
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Although women are known to have lower rates of survival after an acute myocardial infarction 
(AMI) than men, which is largely explained by differences in age and clinical comorbdities
1
, it is 
unknown whether women also have worse quality of life and more frequent angina after AMI, even 
after adjusting for clinical, socioeconomic, and psychological factors that are known to differ by sex.  
Determining whether sex differences exist for not only traditional ‘hard’ clinical end points (e.g., 
death and readmission) but also for health status (symptoms, quality of life) is important because 
these latter outcomes affect patients’ burden of illness, are increasingly recognized as important 
patient-centered outcomes in clinical studies, and are potentially modifiable through additional anti-
anginal therapy or coronary revasuclarization.
2, 3
  
 To date, most prior studies on AMI have typically collected information on ‘hard’ clinical 
end points, such as death and recurrent AMI, or have used generic health status instruments to assess 
patients’ health status.  However, generic instruments are less informative than disease-specific 
health status instruments as the former lack information on whether patients continue to be burdened 
by symptoms specific to their disease, such as angina after AMI.
4
  The emergence of the Seattle 
Angina Questionnaire (SAQ)
5
—a disease-specific instrument for patients with coronary artery 
disease, which has been shown to be reliable, valid, responsive to clinical change, and prognostic of 
mortality, provides a unique opportunity to assess whether women, in addition to having lower 
survival, also have worse health status outcomes after AMI.   
 To address this gap in knowledge, we leveraged health status data from two large multi-
centered AMI registries that contained detailed information on patients’ health status, economic 
status, and psychosocial factors. We were thus able to adjust for a range of differences between men 
and women to examine whether patient’s sex was independently associated with disease-specific 
2 
 
health status recovery (change in quality of life and residual angina) 1 year after AMI.  If differences 
exist, we sought to further identify which patient and treatment factors may explain sex differences 
in these health status outcomes. We also examined whether there was an interaction between 
patients’ age and sex to determine whether sex differences in health status recovery was prevalent 
for both younger (less than 55 years) and older patients (greater than 55 years).  Results from these 
analyses can inform our understanding of the extent and potential mediators of sex differences in 




















Study Population and Data Sources  
We used data from two US-based, multi-center, prospective, observational registries of consecutive 
AMI patients—the TRIUMPH
6
 (Translational Research Investigating Underlying Disparities in 
Acute Myocardial Infarction Patients’ Health Status) and PREMIER
7
 (Prospective Registry 
Evaluating Outcomes After Myocardial Infarctions: Events and Recovery) registries, which enrolled 
AMI patients from 2003 through 2008. Specifically, from 2003-04, 2498 MI patients from 19 U.S. 
hospitals were enrolled in PREMIER, and between 2005-08, 4340 MI patients from 24 U.S. 
hospitals were enrolled in TRIUMPH (12 hospitals participated in both registries). Both studies 
employed similar data collection processes and collected similar data elements, enabling pooling of 
their results.   
Briefly, patients in both studies were eligible for inclusion if they were 18 years or older, had 
elevated cardiac enzymes (troponins or creatinine kinase-MB) within 24 hours of hospital admission 
and had supporting evidence suggestive of AMI, including either prolonged ischemic symptoms or 
electrocardiographic ST-changes.  Exclusion criteria included patients who were incarcerated, 
refused participation, were unable to provide consent, did not speak English or Spanish, were 
transferred to the participating hospital from another facility >24 hours after initial admission, or 
expired prior to being contacted by the investigators.  Demographic, social, clinical, health status and 
psychological data for patients were collected from chart abstraction and baseline interviews by 
trained staff within 24 to 72 hours of the index AMI admission. All participating patients provided 
informed consent, and the study protocol was approved by the institutional review board at each 
participating center.  
4 
 
A total of 6838 AMI patients were enrolled in PREMIER (n = 2498) and TRIUMPH (n = 
4340).  Because we were interested in examining health status outcomes of patients at 1-year after 
hospital discharge, we excluded 41 patients who were missing baseline QOL scores and 2,242 
patients who did not have a health status outcome assessment at 1-year (477 patients died prior to the 
1-year follow-up and 1765 did not complete a 1-year health status assessment).  Our final study 
cohort comprised 4555 AMI patients (Figure 1). 
 
Health Status Outcomes 
The primary outcomes in this study were angina and quality of life.  These were measured using  the 
disease-specific Seattle Angina Questionnaire (SAQ)—a validated, reliable, and responsive health 
status instrument for patients with coronary artery disease that has been shown to be prognostic of 
future mortality, readmissions for acute coronary syndrome, and costs.
4, 5, 8-10
 For this study, we 
focused on the SAQ Angina Frequency and Quality of Life domains, as these likely represent the 
most important health status domains for patients. Patient responses to the SAQ were translated for 
each domain onto a scale from 0 to 100, with higher scores indicating less frequent angina and better 
quality of life. We evaluated 1-year scores for each domain, as well as health status recovery (1- year 
improvement in angina and quality of life).  Finally, to facilitate the clinical interpretability of the 
SAQ Angina Frequency scale, we also dichotomized this scale into any (SAQ Angina Frequency 
score <100) or no (SAQ Angina Frequency score = 100) angina.   
 
Study variables 
The key independent variable in this study was patients’ sex. In addition, both PREMIER and 
TRIUMPH collected information on age and race (white, black, and other). Clinical and treatment 
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variables were collected and included medical comorbidities (chronic lung disease, chronic kidney 
disease, congestive heart failure, diabetes,  hypercholesterolemia, hypertension, peripheral arterial 
disease, prior angina, prior MI, prior percutaneous coronary intervention [PCI] or coronary artery 
bypass surgery [CABG], prior stroke), and smoking history.  Information on AMI severity were also 
obtained including Killip class (class I/II vs. III/IV), and type of AMI (ST elevation vs. non-ST 
elevation).  The registries also collected detailed data on socioeconomic factors and depression
11, 12
, 
as these are important potential confounders of the relationship between patients’ sex and health 
status outcomes.  Socioeconomic factors included marital, perceived social support, depression, 
insurance coverage, employment status, and perceived financial difficulties. Perceived social support 
was measured by the 5-item Enhancing Recovery In Coronary Heart Disease (ENRICHD) Social 
Support Inventory (ESSI).  Based on prior work, low social support was defined as a score of ≤3 on 
2 or more items (excluding items on instrumental social support and marital status) and having a sum 
score of ≤18 on the remaining 5 items.
13
  Depressive symptoms were assessed using the validated 
Patient Health Questionnaire (PHQ-8).
14
  PHQ-8 scores range from 0 to 24, with higher scores 
denoting more severe symptoms and a score of >10 defining major depression.
14
 Financial 
difficulties were assessed during the structured interviews by asking patients the severity of the 
economic burden of medical costs (severe, moderate, somewhat, little, no burden) and if they 
avoided obtaining medical care due to costs.
15
   
Finally, data on AMI treatment was collected, including medications at discharge (beta-
blockers, angiotensin converting enzyme inhibitors or angiotensin receptor blockers, aspirin, and 
statin therapy) and whether the patient was treated with coronary revascularization (PCI or CABG) 





Baseline characteristics between women and men were compared using Student t-tests for 
continuous variables and the chi-square test for categorical variables. We also compared baseline 
and 1-year SAQ quality of life and angina frequency scores between women and men using 
Student’s t-tests, and evaluated for crude differences in health status recovery (i.e., change in SAQ 
quality of life and angina frequency scores at 1 year) using paired t-tests.   
 To examine the extent that any observed sex differences in health status recovery (SAQ 
Angina Frequency and Quality of Life scores) were explained by differences in (1) demographics 
(age and race), (2) clinical factors (comorbidities and severity of MI), (3) socioeconomic and 
psychological factors (marital and employment status, educational level attained, insurance 
coverage, perceived financial difficulties, social support, and depression), and (4) AMI treatment 
(medications at discharge and also whether the patient was treated with coronary revascularization 
during the hospital stay), we constructed sequential hierarchical logistic regression models, to 
account for clustering by site, for each health status measure and adjusted for each of these domains 
in a cumulative fashion. Baseline SAQ scores were included in all models. In these models, patient 
data were nested within hospitals, and hospitals were modeled as random effects, while the 
aforementioned variables were modeled as fixed effects.
16
  We evaluated the degree to which sex 
differences in health status recovery (i.e., improvement in SAQ quality of life and angina frequency 
scores) were attenuated with adjustment for each of these classes of factors and whether sex 
differences persisted even after full model adjustment for all observed factors.  Finally, we examined 
for an interaction between patients’ age (<55 vs. >55) and sex in the final models. There was very 
little missing data in the registries; missing covariates were imputed with 5 imputation data sets 
7 
 
using IVEware (Imputation and Variance Estimation Software; University of Michigan's Survey 
Research Center, Institute for Social Research, Ann Arbor, MI).  
All analyses were conducted with SAS Version 9.2 (SAS Institute, Cary, NC), IVEWARE 
(University of Michigan, MI),
17
 and R Version 2.6.0 (Free Software Foundation, Boston, MA).
18
  All 





We compared patients who were previously excluded to our study cohort (Table 1). Of the 2283 
missing patients, 775 (33.9%) were women. Missing cohort was mostly non-Caucasian, younger, 
and did not have health insurance. Of the 4,555 patients in the cohort, 1,481(32.5%) were women 
(Table 2). Women were older and more frequently of black race. Clinically, women were less likely 
to have an ST elevation MI but higher MI severity (i.e., higher Killip class) during the index 
hospitalization.  They were also more likely to have co-existing chronic lung disease, diabetes 
mellitus, hypertension, but were less likely to have prior angina, MI, and coronary revascularization 
(Table 2). Women were more frequently widowed, and were more likely to be unemployed, have 
more severe depressive symptoms, and have economic barriers to care, including financial difficulty 
affording medications (Table 2). Finally, women were less likely to be discharged on a beta blocker, 
aspirin, and statin for their AMI, and they were also less likely to be treated with coronary 
revascularization (PCI or CABG) during their index hospitalization. (Table 2)  
 
Quality of Life 
Compared with men, women had lower baseline QOL scores (61.3 ± 23.4 vs. 64.9 ± 22.7; 
P<0.001). At 1 year, women continued to have lower QOL scores.  In unadjusted models, 1-year 
change in QOL scores was similar between men and women (absolute difference of -0.39 [95% 
CI: -1.98 to 1.19]).  However, after adjustment for baseline QOL scores and other demographics, 
women had a 4-point lower improvement in QOL scores than men at 1 year (-4.13 [95% CI: -
2.94 to -5.31]) (Figure 2).  These sex differences were essentially unchanged after adjustment for 
clinical comorbidities and AMI severity and were only modestly attenuated after full adjustment, 
including for sex differences in socioeconomic factors, psychological factors, and AMI 
9 
 
treatment, (-2.60 [95% CI: -3.90 to -1.31] P<0.001).  Lastly, there was no interaction between 
patients’ age (<55 vs. >55) and sex in 1-year change in QOL (P for interaction of 0.68), 
suggesting that both younger and older women had worse 1-year improvement in QOL than 
similarly aged men. 
 
Angina    
At their index hospitalization for AMI, women and men had similar baseline SAQ angina frequency 
scores (85.0 ± 20.7 vs. 85.8 ± 20.4; P=0.21). By 1-year follow-up, however, women had 
significantly lower angina frequency scores (91.6 ± 17.6 vs. 94.1 ± 14.9; P<0.001) (see Table 3).  In 
unadjusted models, women had a slightly, but non-significantly, lower improvement in angina scores 
at 1 year compared with men (difference in 1-year change in angina frequency scores between 
women and men: -1.58 [95% CI: -2.97 to -0.20]).  This sex difference in improvement in SAQ 
angina frequency scores at 1 year widened after adjustment for baseline angina frequency score and 
demographics, and did not meaningfully change after even after full adjustment for clinical, 
socioeconomic factors, psychological factors, and AMI treatment, (-2.85 [95% CI: -4.36 to -1.34]; 
P<0.001) (Figure 3).There was no interaction between patients’ age (<55 vs. >55) and sex in 1-year 
change in angina (P for interaction of 0.14). Importantly, when 1-year achieved angina scores was 
evaluated as a dichotomous variable of any vs. no angina at 1 year, women had a 27% increased 
odds of having any angina at 1-year (adjusted Odds Ratio: 1.28 [95% CI: 1.07 to 1.52; P=0.001) 







In this multi-site study of AMI patients, we found that women have worse 1-year health status 
after AMI than men, with smaller improvements in both QOL and angina than men. These 
differences persisted even after adjusting for numerous demographics, clinical comorbidities, 
AMI severity and treatment.  For the outcome of change in 1-year change in QOL, additional 
adjustment for socioeconomic and psychological factors modestly attenuated (~40% narrowing, 
from -4.1 points to -2.6 points) sex differences in 1-year improvement in QOL scores, although 
there remained less improvement in QOL among women than men.  In contrast, for 1-year 
angina frequency, further adjustment for socioeconomic confounders, psychological factors, and 
AMI treatment did not attenuate sex differences.  While the clinical importance of a 3 to 5 point 
difference on the SAQ may not be particularly intuitive, we also found this difference in SAQ 
improvement translated into a 28% greater likelihood of women having angina at 1-year after an 
AMI as compared with men. Collectively, our findings highlight that women have less robust 
improvements in QOL and angina symptoms after an incident AMI, even after accounting for 
non-clinical factors known to be influential in sex-based research.   
Many prior studies have examined sex differences in mortality after AMI.  Indeed, a recent 
systematic review identified 39 studies which presented data on mortality after AMI for men and 
women and found that, although most of these studies reported higher unadjusted mortality rates for 
women compared with men, sex differences were largely attenuated after adjustment for differences 
in age and clinical characteristics.
1
     
In contrast, few studies have examined the association of patients’ sex and health status after 
AMI.  Wiklund et al. surveyed 595 AMI survivors two decades ago and found that women had 





  Emery et al. followed 410 patients with a variety of cardiac diseases for one year 
and found that women had lower QOL on the SF-36, compared with men.
20
  Xu et al. reported that 
women have less improvement in QOL at 1-month after AMI using the Euro-Qol utility index.
21
  
None of these studies, however, used a disease-specific instrument to assess patients’ health status 
after AMI or adjusted for important socioeconomic and psychological confounders of the association 
between sex and health status.  More recently, in a multi-center registry of AMI patients < 55 years 
of age and younger, Dreyer et al. found that women had worse baseline and 1-year health status than 
men  but similar absolute improvements in SAQ scores between baseline and 1-year.
22
 Our study 
extends the work of these investigators by examining sex differences in health status improvement in 
QOL and angina symptoms after AMI in all AMI patients, regardless of age.  We found that, 
compared with men, women had significantly less improvement in QOL and angina symptoms 1-
year after their AMI, even after adjusting for a wide variety of potentially confounding demographic, 
clinical, socioeconomic, psychological, and AMI treatment.  Moreover, our interaction analyses 
suggest that sex differences in health status recovery was prevalent for both younger patients (<55) 
and older (>55) patients. 
 An important finding in this study was that the baseline differences in age, race, and clinical 
comorbidities between men and women did not explain our findings of sex differences in health 
status recovery after AMI.  Although women were older, were more frequently of black race, had a 
higher Killip class, and had higher rates of chronic lung disease, diabetes mellitus, and hypertension 
than men, adjustment for these factors did not narrow sex differences in 1-year improvements in 
QOL or angina. This stands in contrast to mortality
1
, wherein differences in age and clinical factors 
have been found to mediate much of the raw mortality differences between men and women. 
Adjustment for certain socioeconomic and psychological factors, such as educational and 
12 
 
employment status, financial difficulties with accessing medical care, and social support, did reduce 
by ~40% sex differences in QOL improvement after AMI but had no impact on sex differences in 
improvement in angina symptoms.  However, it remains unclear whether these factors are easily 
modifiable by interventions.  Finally, although sex differences in discharge medication treatment and 
coronary revascularization existed, these were not found to be mediators of sex differences in health 
status recovery for either QOL or angina.   
Our study should be interpreted in the context of the following potential limitations. 
Although we were able to account for a rich variety of clinical and non-clinical confounders not 
typically collected in sex disparities research, the possibility of residual confounding remains, given 
that our study was observational in nature. Second, we detected only modest sex differences in 1-
year recovery of QOL and angina. However, this difference of 3 to 5 points in SAQ scores is 
comparable to the clinical benefit obtained from percutaneous coronary intervention as compared 
with medical therapy in randomized trials and is therefore meaningful.
23
  Finally, we were unable to 
assess the factors underlying residual sex differences in 1-year improvement in QOL and angina, 
even after adjustment for a number of important confounders.  Whether these residual differences 
represent differences in reporting of health status recovery between men and women, unmeasured 
treatments (e.g., sex differences in outpatient care or use of cardiac rehabilitation), or unmeasured 
sex differences in clinical, social, and economic factors remains unknown and is worthy of further 
study.    
After an AMI, women have worse health status recovery than men, with lower quality of life 
and more frequent angina. Although some of this is explained by social, economic, and 
psychological factors, there remain sex differences in the trajectory of health status improvement 
after adjusting for these factors as well as AMI treatment. Since we did find that women were less 
13 
 
likely to receive coronary revascularization and evidenced-based medications after AMI, greater 
attention is needed to ensure that this gap in treatment is eliminated to ensure that women have the 
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   Table 1:Patient Characteristics 
 
 
   
p-value Total 
n = 6838 
Missing Study cohort 
n = 2283 n = 4555 
 
Demographics 
    
 Sex    0.234 
     Male 4582 (67.0%) 1508 (66.1%) 3074 (67.5%) 
     Female 2256 (33.0%) 775 (33.9%) 1481 (32.5%) 
Age 59.7 ± 12.6 58.4 ± 13.5 60.4 ± 12.1 < 0.001 
Race    < 0.001 
     White/Caucasian 4499 (66.5%) 1215 (53.9%) 3284 (72.7%) 
     Black/African American 1644 (24.3%) 775 (34.4%) 869 (19.2%) 
     Other 627 (9.2%) 263 (11.7%) 364 (8.1%) 
     Missing  68 30 38 
 
Comorbidities 
    
Chronic Lung Disease 648 (9.5%) 260 (11.4%) 388 (8.5%) < 0.001 
Chronic Renal Failure 573 (8.4%) 268 (11.7%) 305 (6.7%) < 0.001 
Congestive Heart Failure 674 (9.9%) 334 (14.6%) 340 (7.5%) < 0.001 
Diabetes 2056 (30.1%) 785 (34.4%) 1271 (27.9%) < 0.001 
Hypercholesterolemia 3352 (49.0%) 1054 (46.2%) 2298 (50.5%) < 0.001 
Hypertension 4483 (65.6%) 1576 (69.0%) 2907 (63.8%) < 0.001 
Peripheral Arterial Disease 399 (5.8%) 151 (6.6%) 248 (5.4%) 0.051 
Prior Angina 1087 (15.9%) 367 (16.1%) 720 (15.8%) 0.774 
Prior MI 1449 (21.2%) 572 (25.1%) 877 (19.3%) < 0.001 
Prior PCI 1298 (19.0%) 468 (20.5%) 830 (18.2%) 0.023 
Prior CABG 818 (12.0%) 281 (12.3%) 537 (11.8%) 0.532 
Prior CVA or Prior TIA 516 (7.5%) 200 (8.8%) 316 (6.9%) 0.007 
History of Smoking 4118 (60.2%) 1445 (63.3%) 2673 (58.7%) < 0.001 
 
MI Characteristics 
    
MI Killip Class    < 0.001 
     I 5557 (86.8%) 1786 (83.3%) 3771 (88.5%) 
     II 659 (10.3%) 280 (13.1%) 379 (8.9%) 
     III 123 (1.9%) 62 (2.9%) 61 (1.4%) 
     IV 65 (1.0%) 17 (0.8%) 48 (1.1%) 









Marital Status    < 0.001 
     Married 3663 (54.0%) 976 (43.2%) 2687 (59.3%) 
     Divorced 1122 (16.5%) 417 (18.5%) 705 (15.6%) 
     Widowed 809 (11.9%) 311 (13.8%) 498 (11.0%) 
     Single (never married) 768 (11.3%) 355 (15.7%) 413 (9.1%) 
     Other 427 (6.3%) 198 (8.8%) 229 (5.1%) 
     Missing  49 26 23 
ENRICHD Social Support Score  21.9 ± 4.5 21.4 ± 5.0 22.2 ± 4.2 < 0.001 
     Missing 211 92 119 
PHQ Depression Score  5.4 ± 5.4 5.9 ± 5.7 5.1 ± 5.3 < 0.001 
     Missing 415 181 234 
 
Economic factors 
    
No health insurance 1250 (18.9%) 551 (24.9%) 699 (15.8%) < 0.001 
Insurance coverage for medications  4929 (73.4%) 1487 (66.8%) 3442 (76.7%) < 0.001 
Economic burden of medical costs    < 0.001 
     Severe burden 712 (10.6%) 286 (12.9%) 426 (9.5%) 
     Moderate burden 632 (9.4%) 227 (10.2%) 405 (9.0%) 
     Somewhat burden 726 (10.8%) 261 (11.8%) 465 (10.3%) 
     Little burden 619 (9.2%) 194 (8.7%) 425 (9.4%) 
     No burden at all 4031 (60.0%) 1252 (56.4%) 2779 (61.8%) 
     Missing 118 63 55 
Avoided healthcare due to cost 1530 (22.9%) 603 (27.3%) 927 (20.7%) < 0.001 
 Not taken medication due to cost     < 0.001 
     Always 174 (2.6%) 81 (3.6%) 93 (2.1%) 
     Frequently 346 (5.1%) 147 (6.6%) 199 (4.4%) 
     Occasionally 530 (7.9%) 218 (9.8%) 312 (6.9%) 
     Rarely 427 (6.3%) 164 (7.4%) 263 (5.8%) 
     Never 5270 (78.1%) 1619 (72.6%) 3651 (80.8%) 
     Missing  91 54 37 
Employment status    0.001 
     Fullt-time 2558 (37.8%) 797 (35.5%) 1761 (39.0%) 
     Part-time 614 (9.1%) 189 (8.4%) 425 (9.4%) 
     Unemployed 3589 (53.1%) 1261 (56.1%) 2328 (51.6%) 











     Beta Blocker  6070 (89.3%) 1957 (87.3%) 4113 (90.3%) < 0.001 
     ACE or ARB  5024 (73.9%) 1684 (75.1%) 3340 (73.3%) 0.114 
     Aspirin  6344 (93.3%) 2059 (91.8%) 4285 (94.1%) < 0.001 
     Statin 












Table 2: Baseline Characteristics of the Study Cohort 
  










(n=1481) P value 
 
Demographics         
Age 60.4 ± 12.1 59.3 ± 11.5 62.6 ± 12.9 < 0.001 
Race       < 0.001 
     White  3284 (72.7%) 2339 (76.7%) 945 (64.4%)   
     Black 869 (19.2%) 447 (14.7%) 422 (28.8%)   
     Other 364 (8.06%) 264 (8.66%) 100 (6.82%)   
     Missing  38 24 14   
 
Comorbidities 
    Chronic lung disease 388 (8.5%) 215 (7.0%) 173 (11.7%) < 0.001 
Chronic renal failure 305 (6.7%) 207 (6.7%) 98 (6.6%) 0.88 
Congestive heart failure 340 (7.5%) 214 (7.0%) 126 (8.5%) 0.06 
Diabetes 1271 (27.9%) 785 (25.5%) 486 (32.8%) < 0.001 
Hypercholesterolemia 2298 (50.5%) 1573 (51.2%) 725 (49.0%) 0.16 
Hypertension 2907 (63.8%) 1845 (60.0%) 1062 (71.7%) < 0.001 
Peripheral Arterial Disease 248 (5.4%) 157 (5.1%) 91 (6.1%) 0.15 
Prior Angina 720 (15.8%) 509 (16.6%) 211 (14.2%) 0.05 
Prior MI 877 (19.3%) 618 (20.1%) 259 (17.5%) 0.04 
Prior PCI 830 (18.2%) 601 (19.6%) 229 (15.5%) < 0.001 
Prior CABG 537 (11.8%) 397 (12.9%) 140 (9.5%) < 0.001 
Prior CVA or Prior TIA 316 (6.9%) 196 (6.4%) 120 (8.1%) 0.03 
History of Smoking 2673 (58.7%) 1915 (62.3%) 758 (51.2%) < 0.001 
 
MI Characteristics 
    MI Killip Class 
   
0.002 
     I 3771 (88.5%) 2578 (89.8%) 1193 (86.0%) 
      II 379 (8.9%) 222 (7.7%) 157 (11.3%) 
      III 61 (1.4%) 39 (1.4%) 22 (1.6%) 
      IV 48 (1.1%) 33 (1.1%) 15 (1.1%) 
      Unknown 296 202 94 
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Total  Male  Female  
  (n=4555) (n=3074) (n=1481) P value 
 
Psychosocial factors         
Marital Status       < 0.001 
     Married 2687 (59.3%) 2067 (67.6%) 620 (42.1%)   
     Divorced 705 (15.6%) 428 (14.0%) 277 (18.8%)   
     Widowed 498 (11.0%) 155 (5.1%) 343 (23.3%)   
     Single (never married) 413 (9.1%) 267 (8.7%) 146 (9.9%)   
     Other 229 (5.1%) 142 (4.6%) 87 (5.9%)   
     Missing  23 15 8   
ENRICHD Social Support Score 22.2 ± 4.2 22.3 ± 4.1 22.0 ± 4.2 0.03 
     Missing 119 84 35   
PHQ Depression Score  5.1 ± 5.3 4.6 ± 4.9 6.3 ± 5.7 < 0.001 
     Missing 234 145 89   
 
Economics factors         
No health insurance 699 (15.8%) 481 (16.2%) 218 (15.1%) 0.35 
Insurance coverage for 
medications 3442 (76.7%) 2377 (78.6%) 1065 (72.9%) < 0.001 
Economic burden of medical 
costs       0.001 
     Severe burden 426 (9.5%) 254 (8.4%) 172 (11.8%)   
     Moderate burden 405 (9.0%) 272 (9.0%) 133 (9.1%)   
     Somewhat burden 465 (10.3%) 299 (9.8%) 166 (11.3%)   
     Little burden 425 (9.4%) 287 (9.5%) 138 (9.4%)   
     No burden at all 2779 (61.8%) 1925 (63.4%) 854 (58.4%)   
     Missing 55 37 18   
Avoided healthcare due to cost 927 (20.7%) 594 (19.6%) 333 (22.8%) 0.02 
Employment Status       < 0.001 
     Full-time 1761 (39.0%) 1397 (45.9%) 364 (24.8%)   
     Part-time 425 (9.4%) 285 (9.4%) 140 (9.5%)   
     Unemployed 2328 (51.6%) 1362 (44.7%) 966 (65.7%)   
     Missing 41 30 11   
Not taking medications due to 
cost       < 0.001 
     Always 93 (2.1%) 56 (1.8%) 37 (2.5%)   
      Frequently 199 (4.4%) 118 (3.9%) 81 (5.5%)   
     Occasionally 312 (6.9%) 180 (5.9%) 132 (9.0%)   
     Rarely 263 (5.8%) 158 (5.2%) 105 (7.2%)   
     Never 3651 (80.8%) 2538 (83.2%) 1113 (75.8%)   













(n=1481) P value 
 
AMI Treatment 
    Beta Blocker 4113 (90.3%) 2794 (90.9%) 1319 (89.1%) 0.05 
ACE-I or ARB 3340 (73.3%) 2279 (74.1%) 1061 (71.6%) 0.07 
Aspirin 4285 (94.1%) 2918 (94.9%) 1367 (92.3%) < 0.001 
Statin 3921 (86.1%) 2701 (87.9%) 1220 (82.4%) < 0.001 
Revascularization:  
PCI or CABG (primary or other) 3495 (76.7%) 2485 (80.8%) 1010 (68.2%) < 0.001 
Abbreviations: ENRICHD = Enhancing Recovery In Coronary Heart Disease;
 
PHQ = Patient Health 
Questionnaire; ACE-I = angiotensin converting enzyme inhibitor; ARB = angiotensin receptor blocker 
    
     
    
      
22 
 
Table 3: Baseline and 1-Year Health Status By Sex 
          
  Total  Male  Female    
  (n=4555) (n=3074) (n=1481) P value 
Baseline          
     SAQ Quality of Life 63.8 ± 23.0 64.9 ± 22.7 61.3 ± 23.4 < 0.001 
     SAQ Angina Frequency 85.6 ± 20.5 85.8 ± 20.4 85.0 ± 20.7 0.21 
 
12-month         
     SAQ Quality of Life 83.0 ± 19.9 84.2 ± 19.0 80.3 ± 21.5 < 0.001 
     SAQ Angina Frequency 93.3 ± 15.8 94.1 ± 14.9 91.6 ± 17.6 < 0.001 









Patients who died during index 
hospitalization or prior to 1-year follow-
up (n=477)   
Patients without follow up 1-year SAQ 
QOL scores (n=1765) 
Patients missing baseline SAQ QOL 
scores (n=41) 
Patients with AMI n=6838 
PREMIER n=2498 
TRIUMPH n=4340 










Figure 2. Sex Difference in 1-Year QOL Health Recovery.* At 1 year, women had less 













*A negative estimate suggests that women had less improvement in 1-year QOL scores on the SAQ, 
whereas a positive estimate suggests that women had greater improvement. 
a
AMI treatment refers to medication at discharge and whether the patient was treated with coronary 
revascularization during the hospital stay 
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Figure 3. Sex Difference in 1-Year Angina Frequency Health Recovery.* At 1 year, women had 























*A negative estimate suggests that women had less improvement in 1-year angina frequency scores 
on the SAQ, whereas a positive estimate suggests that women had greater improvement. 
a
AMI treatment refers to medication at discharge and whether the patient was treated with coronary 
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Figure 4. Sex Difference in Odds of any Angina at 1-Year. At 1 year, women had 28% increased 



























AMI treatment refers to medication at discharge and whether the patient was treated with coronary 
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